Home
Sign In
About
Curriculum
Activity Information
Target Audience
Learning Objectives
Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
Course materials have been developed for use outside of the United States.
|
 |
|
|
|
|
|
|
Epidemiology and Disease Pathophysiology:
Hereditary Haemochromatosis
In this webcast, Pierre Brissot, MD, provides a review of the epidemiology and pathophysiology of hereditary haemochromatosis (HHC), including the key role of hepcidin. The diagnosis and management of this disease is also discussed, and how HHC relates to the development of iron overload.
|
|
Faculty
|
|
|
Pierre Brissot, MD
Professor of Medicine
Liver Disease Department
University Hospital Pontchaillou
Rennes, France
|
|
|
Target Audience
This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
|
Learning Objectives
After participating in this activity, participants should be better able to:
- Classify the various types of inherited haemochromatosis, including underlying genetic mechanisms and clinical presentation to improve diagnosis and management of this disorder.
- Discuss the epidemiology and disease pathophysiology of hereditary haemochromatosis and recognize that patients with this disorder may be affected by the factors that lead to the development of iron overload.
|
Disclosure Information
Pierre Brissot, MD, has received grant/research support from and is on the speakers bureau of Novartis Pharmaceuticals Corporation. Prof. Brissot has disclosed that he will not reference any unlabeled/unapproved uses of drugs or devices.
|
|
|
|
|
|
|
